McMaster Partnership Supports Ontario’s Growing Life Sciences Sector
A new McMaster University partnership with U of T and Genesys Capital will support early-stage life sciences startups across Ontario, helping strengthen the province’s health innovation and commercialization ecosystem.
Jul 8, 2026
Hamilton is Home to New EV Innovation Hub
Hamilton is advancing its role in clean transportation with the launch of a new EV innovation hub at McMaster Innovation Park. The partnership brings together leading researchers, industry partners, and government to accelerate the development and commercialization of next-generation electric vehicle technologies—strengthening the city’s position as a hub for automotive innovation and sustainable mobility.
May 21, 2026
Hamilton Life Sciences Companies Receive Ontario Funding to Advance Health Innovation
Four Hamilton-connected life sciences companies — Esphera SynBio, NodeAI, Stoked Bio, and Synmedix — are receiving support through Ontario’s Life Sciences Innovation Fund to commercialize health technologies, AI diagnostics and next-generation therapeutics.
May 11, 2026
Feds and OmniaBio partner to expand Hamilton facility for revolutionary cell and gene therapies
The Government of Canada announced a collaboration with OmniaBio to expand its facility at McMaster Innovation Park. This expansion will focus on manufacturing cell and gene therapies, providing production services globally, and strengthening Canada's role in global value chains. The project aims to revolutionize treatments for chronic diseases such as cancer, autoimmune conditions, diabetes, cardiovascular, and neurological diseases.
Apr 3, 2025
OmniaBio launches Canada’s largest cell and gene therapy manufacturing facility
New facility to drive biotech innovation with advanced AI and robotics, creating jobs and boosting local economy
Oct 17, 2024
McMaster-led study to revolutionize cancer care backed by $4.9M Pfizer investment
McMaster University leads groundbreaking study to transform multiple myeloma treatment